Iradimed Co - Asset Resilience Ratio

Latest as of December 2022: 0.00%

Iradimed Co (IRMD) has an Asset Resilience Ratio of 0.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IRMD net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$85.51 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2022)

This chart shows how Iradimed Co's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Iradimed Co (IRMD) total assets.

Liquid Assets Composition Over Time

This chart breaks down Iradimed Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Iradimed Co (IRMD) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Iradimed Co maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Iradimed Co Industry Peers by Asset Resilience Ratio

Compare Iradimed Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medtronic plc
SA:MDTC34
Medical Devices 7.82%
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Theradiag SA
PA:ALTHE
Medical Devices 15.59%
Biosynex
PA:ALBIO
Medical Devices 3.35%

Annual Asset Resilience Ratio for Iradimed Co (2012–2022)

The table below shows the annual Asset Resilience Ratio data for Iradimed Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.00% $0.00 $85.51 Million --
2021-12-31 0.61% $501.86K $82.88 Million -2.08pp
2020-12-31 2.69% $1.91 Million $71.07 Million -1.46pp
2019-12-31 4.15% $2.77 Million $66.73 Million -8.96pp
2018-12-31 13.11% $6.35 Million $48.44 Million -7.74pp
2017-12-31 20.85% $8.14 Million $39.01 Million -0.56pp
2016-12-31 21.42% $7.97 Million $37.19 Million -0.15pp
2015-12-31 21.57% $7.60 Million $35.24 Million -12.38pp
2014-12-31 33.95% $7.91 Million $23.31 Million +30.43pp
2013-12-31 3.52% $246.20K $6.99 Million -0.99pp
2012-12-31 4.52% $250.79K $5.55 Million --
pp = percentage points

About Iradimed Co

NASDAQ:IRMD USA Medical Devices
Market Cap
$1.06 Billion
Market Cap Rank
#8662 Global
#2488 in USA
Share Price
$82.74
Change (1 day)
+0.19%
52-Week Range
$68.55 - $105.15
All Time High
$105.15
About

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs moni… Read more